Market Trends of Brazil Nuclear Imaging Industry
This section covers the major market trends shaping the Brazil Nuclear Imaging Market according to our research experts:
Oncology Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Due to the rising prevalence of diseases, technological improvements, the launch of novel radiopharmaceuticals for diagnosis, and the advancement of molecular imaging, Brazil is anticipated to account for the market's growth. In addition, the prevalence of chronic diseases is rising, as is the usage of PET and SPECT scans. The Global Cancer Observatory forecasts that Brazil will see 259,949 cancer deaths and an estimated 592,212 new cancer cases in 2020. The demand for nuclear imaging is anticipated to rise as a result of increased launches by major market participants in the sector, a growth in regulatory body approvals, as well as numerous agreements and collaborations across the nation. For instance, Grupo RPH and gate-Startup OncoBeta GmbH sign a contract in September 2020 for the sale, distribution, and treatment of rhenium-induced skin cancer in Brazil. In the article "Evaluation of the Clinical Use of PET/CT with 68 Ga-PSMA for the Assessment of Biochemical Recurrence of Low or Intermediate-Risk Prostate Cancer," published in 2021, André Marcondes Braga Ribeiro of the A.C. Camargo Cancer Center in So Paulo stated that 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography is useful for the Assessment of Biochemical Recur. Thus, due to the abovementioned factros the market is expected to grow in the future.
